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Abstract We studied the effects of nitric oxide (NO) on 
prostanoid production, cyclooxygenase (COX-2) expression and 
[3H1 arachidonic acid (AA) release in RAW 264.7 macrophagic 
cells and rat microglial primary cultures. Inhibition of NO 
synthesis enhanced microglial prostanoid production without 
affecting that of RAW 264.7 cells. Both 3-morpholinosydnoni-
mine (SIN-1), (which, by releasing NO and superoxide, leads to 
the formation of peroxynitrite), and S'-nitroso-A'-acetylpenicilla-
mine (SNAP), (which releases only NO), inhibited microglial 
prostanoid production, by preventing COX-2 expression. In 
contrast, in RAW 264.7 cells, SIN-1 enhanced both basal and 
LPS-stimulated prostanoid production by upregulating COX-2, 
while SNAP stimulated basal production and slightly inhibited 
the LPS-induced production, as a cumulative result of enhanced 
AA release and depressed COX-2 expression. Thus, reactive 
nitrogen intermediates can influence prostanoid production at 
distinct levels and in different way in the two cell types, and 
results obtained with RAW 264.7 cells can not be extrapolated to 
microglia. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Prostaglandins (PGs), the arachidonic acid (AA) metabo-
lites of the cyclooxygenase (COX) pathway, and nitric oxide 
(NO), whose formation from L-arginine is catalysed by NO 
synthase (NOS), play major roles in regulating inflammation, 
immune functions, blood vessel dilatation and neurotransmis-
sion [1]. Both COX and NOS exist in two major isoforms: the 
constitutive forms (COX-1 and cNOS) are present in many 
cells and are responsible for the production of PGs and NO 
involved in physiological functions; the inducible forms 
(COX-2 and iNOS) are rapidly up-regulated upon appropriate 
stimulation. COX-2 and iNOS are the major isoforms ex-
pressed in inflammatory cells and catalyse the production of 
high levels of PGs and NO, present in pathological condi-
tions, such as acute or chronic inflammation [2,3]. 
Interactions between PGs and NO are of particular interest 
at inflammatory sites, where their synthesis is often elicited by 
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the same stimuli (pro-inflammatory cytokines, bacterial endo-
toxin, etc.), and where they may exert synergistic as well as 
antagonistic actions on common targets. Modulation of the 
COX pathway by NO has been studied in several systems with 
no uniform results [4]. Yet, the results obtained with one 
particular system are often extrapolated to macrophages in 
general and microglia in particular. In a previous study we 
have shown that NO down-regulates COX-2 expression and 
PG production in microglial cells, the brain resident macro-
phages [5], which produce large amounts of NO and PGs in 
response to LPS [6,7]. In other macrophage systems, including 
the monocytic/macrophagic cell line RAW 264.7, NO was 
reported to stimulate PG synthesis [8]. This stimulatory activ-
ity has been related to an interaction of NO with the heme 
group of COX, which would result into an increased enzy-
matic activity. However, the recent finding that NO binding 
with the heme of COX-2 enzyme results in its inactivation 
[9,10], suggests that other mechanisms of interaction between 
NO and COX-2 may account for the increased PG production 
[11]-
In order to understand the reason for the reported conflict-
ing results, we analysed the alterations in the PG metabolic 
pathway in microglia and RAW 264.7 cells, induced by an 
inhibitor of endogenous NO synthesis or by compounds ca-
pable of releasing NO or peroxynitrite, a NO derivative which 
may account for several biological effects of NO [12]. We 
found that NO and affect the PG pathway at different levels 
and often in an opposite way in the two cell types. 
2. Materials and methods 
2.1. Reagents 
The mouse monocytic/macrophagic cell line RAW 264.7 was kindly 
provided by Prof. B. Brune, University of Erlangen-Nurnberg, Ger-
many. RPMI 1640 medium without glutamine was from HyClone 
(Cramlington, UK), Glutamax I supplement containing L-alanyl-glu-
tamine was from Life Technologies (San Giuliano Milanese, Italy). 
LPS (serotype 026:B6), TV6-monomethyl-L-arginine (NMMA), 3-mor-
pholinosydnonimine (SIN-1), S-nitroso-JV-acetylpenicillamine (SNAP) 
were obtained from Sigma (Milan, Italy). [3H]AA (60-100 Ci/mmol) 
and [3H]prostaglandin E2 (PGE2) (171 Ci/mmol) were from Du Pont 
Nuclear (New England). 
2.2. Cell culture and biochemical determinations 
RAW 264.7 cells were maintained in RPMI 1640 medium supple-
mented with 100 U/ml penicillin, 100 ug/ml streptomycin, 10% heat-
inactivated foetal calf serum, 2 mM of Glutamax I (complete RPMI 
1640 medium). Cells were plated at a density of 6X105 cells/cm2 in 
24-well plates. Microglial secondary cultures were prepared from 10-
14-day mixed primary glial cultures obtained from the cerebral cortex 
of 1-day-old rats, as previously described [13]. They were plated on 
plastic in 24-well plates (1.25X10° cells/cm2), allowed to adhere for 
20 min, and washed to remove non-adhering cells. The cultures con-
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sisted of a 99% microglia/macrophages (positive for the macrophage 
marker ED1). Cells were grown in basal Eagle's medium (BME) sup-
plemented with 10% foetal calf serum, 2 mM glutamine and 2 ug/ml 
of gentamicin (complete BME medium). Both cell cultures were al-
lowed to adhere overnight, and stimulated for 24 h with the indicated 
inducers or inhibitors after a medium change. Then culture media 
were collected, centrifuged, and stored at —20°C, until tested. The 
level of PGE2 released into culture media was quantified using a 
specific radioimmunoassay [6]. Detection limit was 25 pg/ml. Nitrite, 
a stable NO oxidation product, was determined using the Griess re-
action [5], by a procedure modified from that of Tracey [14]. Detec-
tion limit was 0.3 uM. 
For the evaluation of COX expression, RAW 264.7 and microglial 
proteins obtained from cell lysates [6] were subjected to western blot 
analysis using specific antibodies for COX-1 and COX-2 isoforms [15]. 
The Amersham ECL system was used to detect the antibodies. Puri-
fied COX-1 (from ram seminal vesicles) and COX-2 (from sheep pla-
centa) were used as standard controls (0.5 ug/lane). Determination of 
COX-2 expression level was performed using the GS-700 Imaging 
densitometer (Bio-Rad). The intensity of the bands was evaluated 
semiquantitatively and the values measured in treated samples were 
always referred to the corresponding control samples, which were run 
in the same gel. 
In order to estimate AA release, RAW 264.7 and microglial cells 
were incubated for 20-22 h in complete media supplemented with 
0.5 uCi/ml [3H]AA, washed (3 times) with complete media, and in-
cubated at 37°C with the indicated test substances for 2 h or 5 h. The 
supernatants were then collected and counted for radioactivity. The 
incorporation pattern of [3H]AA in microglial cells was as already 
described [6] and in RAW 264.7 cells, after a 22 h labelling period, 
was: phosphatidylcholine, 16%; phosphatidylethanolamine, 37%; 
phosphatidylinositol, 22%; phosphatidylserine, 3%; neutral lipids, 
7%. Such [3H]AA distribution remained identical after labelling peri-
ods of 40 and 48 h. 
3. Results 
3.1. Effects of endogenous NO on PGEg synthesis 
R A W 264.7 cells spontaneously released detectable levels of 
both P G E 2 (0.08 ±0 .02 ng/ml, mean ± S.E.M., n = l) and N O 
(3 .23±1.41 u M , m e a n ± S . E . M . , n-3, measured as accumu-
lation of nitrite in culture media). Such basal release was sig-
nificantly increased to 0.41 ± 0.09 ng/ml of P G E 2 and 
16.22 ±3 .45 u M of N O in the presence of 1 ug/ml of LPS. 
The effect of LPS was dose-dependent and was maximal at the 
above concentration (not shown). Microglial cultures from 
both neonatal and adult rat brains are also able to produce 
P G E 2 and N O but compared to R A W 264.7 cells require a 
much lower LPS concentration (10 ng/ml) to achieve optimal 
P G E 2 and N O production [6,7]. The amount of nitrite pro-
duced was similar in the two cell types (around 100 nmol/mg 
protein), when stimulated with optimal LPS concentrations, 
while P G E 2 production was much higher in microglia 
(15.8 ± 2 . 4 ng/mg protein, mean ± S.E.M., n = 4) than in 
control 1 (jg/ml LPS 
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Fig. 1. Effect of the NO donors SIN-1 (100 and 400 uM) (A) and 
SNAP (100 and 500 uM) (B) on the basal and LPS-induced PGE2 
production in RAW 264.7 cells. The cells were incubated for 24 h 
in the presence of the NOS inhibitor NMMA (400 uM), without or 
with 1 ug/ml of LPS. Values are means ± S.E.M. of four independ-
ent experiments assayed in triplicate. *p<0.05 and **p<0.0\ com-
pared with the corresponding control. 
R A W 264.7 cells (2.32 ±0 .55 ng/mg protein, mean ± S.E.M., 
« = 8). 
To assess the regulation of P G E 2 synthesis by endogenous 
N O , we measured P G E 2 production in microglial and R A W 
264.7 cells, after 24 h incubation with optimal LPS concen-
trations in the absence or in the presence of A^-monomethyl-
L-arginine ( N M M A ) , a specific NO-synthase inhibitor (Table 
1). N M M A strongly reduced N O production in both cell 
types, although lower inhibitor concentrations were required 
for microglia. Consistently with previous results [5], the inhi-
bition of N O production in microglia was accompanied by a 
two fold increase of P G E 2 release. Such increase was similar 
with two concentrations of N M M A (20 and 200 uM) causing 
70% and 90% inhibition of N O synthesis, respectively. On the 
other hand, N M M A (200 and 400 uM) inhibited by 70% N O 
Table 1 
Effect of NMMA on LPS-stimulated PGE2 and NO production in RAW 264.7 and microglia 
NMMA 
(MM) 
PGE2 NO, 
(% of LPS) 
RAW 264.7 
LPS (1 ug/ml) 
Microglia 
LPS (10 ng/ml) 
200 
400 
20 
200 
87 ±12 
91 ±8 
204 ±23 
195 ±22 
33 ±5 
27 ±5 
32 ±6 
7 ± 4 
Cells were stimulated with LPS in the presence of NMMA. After 24 h, supernatants were collected and the production of PGE2 and NO (measured 
as nitrite, N02~) determined. LPS-induced production was taken as 100%. Values are means ± S.E.M. of three to four independent experiments, 
assayed in duplicate (microglia) or triplicate (RAW 264.7 cells). 
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Fig, 2. Effect of the NO donor SNAP on the basal and LPS-in-
duced PGE2 production in microglia. Microglial cells were incu-
bated for 24 h in the presence of the NOS inhibitor NMMA 
(200 uM), without or with SNAP (100 uM). Values are means 
±S.E.M. of four independent experiments, assayed in triplicate. 
*p < 0.05 as compared to the LPS-stimulated cells. 
synthesis but did not affect significantly the production of 
PGE2 in RAW 264.7 cells. Higher concentrations of 
NMMA were not tested, to avoid non-specific effects on 
COX activity [1]. While the LPS-stimulated PGE2 production 
found in RAW 264.7 cells was comparable with that reported 
by others, we did not find an inhibition of PGE2 production 
by NMMA as others did [8]. 
3.2. Effects of NO donors on PGE2 synthesis 
The effect of exogenous NO on PGE2 synthesis in RAW 
264.7 and microglial cells was evaluated by using the synthetic 
donors 3-morpholinosydnonimine (SIN-1) and S-nitroso-N-
acetylpenicillamine (SNAP). The concentrations used (100 
and 400 uM for SIN-1; 100 and 500 uM for SNAP), were 
substantially lower than those utilised in other studies [16], 
and produced an accumulation of nitrite in culture media 
which was from 2 to 10 folds higher than that induced by 
LPS. It is difficult to say whether the extracellular NO levels 
achieved in culture media may be close to those reached in 
vivo in the vicinity of activated macrophages or microglia in 
pathological conditions. 
To avoid interference with the endogenously produced NO, 
all the experiments were performed in the presence of the 
inhibitor NMMA (200 uM for microglia and 400 uM for 
RAW 264.7 cells). In RAW 264.7 cells, SIN-1 and SNAP 
dose-dependently increased basal PGE2 production, while 
the LPS-stimulated production was enhanced by SIN-1 and 
moderately decreased, with a statistically significant effect 
only at the lower concentration, by SNAP (Fig. 1). In micro-
glial cultures, both 100 uM SIN-1 [5] and, even more so, 
SNAP (Fig. 2) inhibited the LPS-induced PGE2 production, 
with no effect on basal release. 
3.3. Effects of NO donors on A A release 
The possibility that NO interfered with prostanoid produc-
tion at the level of AA release was investigated. After 2 h 
exposure, LPS dose-dependently stimulated [3H]AA release 
from prelabelled RAW 264.7 cells (50 ±2% and 90 ±17% 
over basal release with 1 and 5 ug/ml of LPS, respectively, 
mean±S.E.M., « = 4), in agreement with previous observa-
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tions in the same cell line [16] and microglial cultures [3]. 
This effect of LPS was not affected by NMMA (400 uM, 
not shown). 
The two NO donors, however, affected in a different way 
[3H]AA release in the two cell types. In RAW 264.7 cells, 
SIN-1 (100 uM) did not affect basal release after 2 h (Fig. 
3A) or 5 h (not shown) of incubation and caused a dubious 
increase in the LPS-induced release (Fig. 3A), which was no 
longer visible at a higher SIN-1 concentration (400 u\M, not 
shown). At variance with SIN-1, SNAP (500 (J.M) markedly 
increased ( > 70%) basal [3H]AA release and moderately en-
hanced the LPS-induced release (25%) in this cell line (Fig. 
3B). Using yet another NO donor, sodium nitroprusside, both 
basal and LPS-induced [3H]AA release were reported to be 
increased in RAW 264.7 cells [17]. In microglial cells, SIN-1 
caused a moderate, but statistically significant decrease of 
both basal (10 ±3%, mean±S.E.M., « = 3) and LPS-stimu-
lated (20 ±5%, mean±S.E.M., n = 3) [3H]AA release, while 
SNAP was devoid of effect. 
3.4. Effects of NMMA, SIN-1 and SNAP on 
COX-2 expression 
Since COX-2 was strongly down-regulated by both endog-
enous and exogenous NO in microglial cells [5], we sought to 
analyse by western blot whether the expression of COX-2 
could be differently affected in RAW 264.7 cells. As for micro-
glial cultures [5], COX-1 was not detectable in RAW 264.7 
cells by western blot analysis, both in basal conditions and 
after stimulation with LPS. In contrast with microglia [5], 
COX-2 expression was clearly detectable in unstimulated 
RAW 264.7 cells (Fig. 4A). Exposure of RAW 264.7 cells to 
* " SIN-1 LPS LPS+SIN-1 
M 
2 220 
SNAP LPS LPS+SNAP 
Fig. 3. [3H]AA release induced by 100 uM SIN-1 (A) and 500 uM 
SNAP (B) in RAW 264.7 cells prelabelled with [3H]AA and then in-
cubated for 2 h with the NO donors, with or without 1 ug/ml LPS. 
The radioactivity released by untreated cells was taken as 100%. 
Values are means ± S.E.M. of four (SIN-1) and three (SNAP) inde-
pendent experiments measured in triplicate. *p<0.05 compared 
with the corresponding control. 
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Fig. 4. Effect of NMMA, SIN-1 and SNAP on LPS-stimulated COX-2 expression in RAW 264.7 cells. Cells were incubated for 24 h in com-
plete medium, with or without 1 |Xg/ml LPS, in the absence or in the presence of NMMA (A), SIN-1 (B) or SNAP (C), at the concentrations 
indicated. Cell lysates were prepared and equal amounts of protein (25 jig) were analysed by western blot using anti-COX-2 specific antibodies 
(1:500). Protein bands were visualised using horseradish peroxidase-conjugated secondary antibodies and ECL. One experiment representative 
of four (A) and three (B, C) is shown. 
LPS (1 |J.g/ml) markedly enhanced COX-2 expression 
(4.8 ± 1.5 fold, mean ± S.E.M., » = 4) (Fig. 4A), and microglia 
behaved in a similar fashion [5]. NMMA (400 uM), which 
enhanced the LPS-induced expression of COX-2 in microglia 
[5], did not affect the basal nor the LPS-induced COX-2 ex-
pression in RAW 264.7 cells (tested in four independent ex-
periments), in agreement with the lack of significant effect of 
NMMA on LPS-stimulated PGE2 production (Table 1). The 
stimulatory effect of SIN-1 (400 uM) on PGE2 production in 
RAW 264.7 cells (Fig. 2A) was paralleled by an increased 
expression of COX-2, which was evident both in basal con-
ditions (44% ±10) and after LPS stimulation (29% ±5), as 
evaluated by densitometric analysis of western blot bands 
(means ± S.E.M., n = 3) (Fig. 4B). A lower concentration of 
SIN-1 (100 (xM) enhanced only slightly the basal expression 
of COX-2 and did not affect that induced by LPS (Fig. 4B). 
After treatment with SNAP (which enhanced basal and de-
pressed LPS-induced PGE2 production in RAW 264.7 cells, 
see Fig. 2B), both basal and LPS-stimulated COX-2 expres-
sion were depressed in a concentration-dependent way (Fig. 
4C). Once again, the effects of SIN-1 and SNAP on RAW 
264.7 cells differed from those on microglia, where SIN-1 
reduced by 47.5% (w = 2, see also ref. [5]) and SNAP almost 
abolished the LPS-induced expression of COX-2 (Fig. 5), 
while neither compound affected the basal (undetectable) ex-
pression of the enzyme. 
4. Discussion 
Increasing evidence indicates that NO can stimulate or in-
hibit PG synthesis, depending on the cell type under investi-
gation. 
By comparing the effect of NO on PGE2 synthesis in pri-
mary microglial cultures and in RAW 264.7 cells, we have 
shown that NO can exert its action at multiple levels of the 
COX pathway. Indeed, in microglial cultures, COX-2 expres-
sion appeared to be the main regulatory step, and its down-
regulation by exogenous NO, released by the synthetic donor 
SNAP, caused a reduction of PGE2 synthesis. In RAW 264.7 
cells the pattern of the effects of SNAP was more complex and 
could be explained as follows: the enhancement of basal 
PGE2 production was likely to be related to a substantially 
increased availability of the PGE2 precursor AA, which could 
counteract the inhibitory effect of the drug on COX-2 expres-
sion. In this basal condition, AA rather than COX-2 avail-
ability could be the major rate-limiting step in PGE2 synthe-
sis. In cells stimulated with LPS, however, the massive 
inhibitory effect of SNAP on COX-2 expression may not be 
counteracted by the small stimulation of AA release observed 
in this condition, with a resulting depression, albeit small, in 
the synthesis of PGE2. 
In addition to SNAP, which (similar to other 5-nitroso-
thiols) is considered to release exclusively NO [18], we also 
studied the effects of SIN-1, a donor of two radicals, 0 2 ~ and 
NO, which may combine to form peroxynitrite (OONO~). 
Peroxynitrite may account for several of the biological effects 
of NO [12,19]. In RAW 264.7 cells, SIN-1 behaved differently 
from SNAP, as it enhanced both basal and LPS-stimulated 
PGE2 production. Such enhancement appeared to be mainly, 
if not exclusively, mediated by an increased expression of 
COX-2. 
As the main difference between SIN-1 and SNAP is the 
ability of the former to generate peroxynitrite, our observa-
tions favour the idea that in RAW 264.7 cells COX-2 expres-
sion is stimulated by peroxynitrite and inhibited by NO, while 
AA release is mainly stimulated by NO. On the other hand, in 
microglia LPS-stimulated COX-2 expression and PGE2 pro-
Fig. 5. Effect of SNAP on basal and LPS-stimulated COX-2 expres-
sion in microglia. Microglial cells were subcultured for 24 h, then 
the medium was renewed and the cells were incubated with or with-
out 10 ng/ml LPS, in the absence or in the presence of 100 uM 
SNAP. After 24 h cell lysates were prepared and analysed as de-
scribed in Fig. 4. 
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duction were both consistently inhibited by SIN-1 and SNAP. 
Therefore, both NO and peroxynitrite would appear to inhibit 
COX-2 expression, while only peroxynitrite exerts a moderate 
depressing effect on AA release. 
In conclusion, major differences exist in the effects of nitro-
gen radicals on PG production between the two macrophagic 
cell types considered in the present study. It is difficult to say 
whether this is due to the adaptation of the microglial phe-
notype to the peculiar cerebral environment, or to the loss of 
the original macrophagic phenotype by the RAW 264.7 cell 
line. Certainly, however, results obtained with RAW 264.7 
cells can not be extrapolated to microglia. 
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